Piekos Brian
Chief Financial Officer at KALV
- Sold, on record
- $165k
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 22, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- KALVKalVista Pharmaceuticals, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
3
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale KALVUnusualNov 24 2025
Sold 4,471 shares at $13.45 ($60k)
Piekos Brian, Chief Financial Officer
No 10b5-1 planSold 29.8% of holdings ($202k position)10,529 shares leftFirst sale on recordFiling
- 2 Form 4 sale KALVNo planFeb 23 +91 days
Sold 1,767 shares at $15.57 ($28k)
Piekos Brian, Chief Financial Officer
No 10b5-1 planSold 11.4% of holdings ($242k position)13,762 shares leftFiling
- 3 Form 4 sale KALVNo planApr 17 +53 days
Sold 1,862 shares at $20.22 ($38k)
Piekos Brian, Chief Financial Officer
No 10b5-1 planSold 9.3% of holdings ($405k position)18,150 shares leftFiling
- 4 Form 4 sale KALVNo planMay 22 +35 days
Sold 1,489 shares at $26.78 ($40k)
Piekos Brian, Chief Financial Officer
No 10b5-1 planSold 6.4% of holdings ($620k position)21,661 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | KALV | Chief Financial Officer | Form 4 sale | 1,489 | $40k | 6.4% | No plan | SEC |
| Apr 17, 2026 | KALV | Chief Financial Officer | Form 4 sale | 1,862 | $38k | 9.3% | No plan | SEC |
| Feb 23, 2026 | KALV | Chief Financial Officer | Form 4 sale | 1,767 | $28k | 11.4% | No plan | SEC |
| Nov 24, 2025 | KALV | Chief Financial Officer | Form 4 sale | 4,471 | $60k | 29.8% | Unusual | SEC |